 |
|
|
| |
Daclatasvir+Asunaprevir versus Sofosbuvir/Ledipasvir
for the Treatment of Chronic Hepatitis C Genotype 1 in Japanese Patients: A Matching-Adjusted Indirect Comparison
|
| |
| |
Reported by Jules Levin
25th Conference of the Asian Pacific Association for the Study of the Liver (APASL), 20-24 February 2016, Tokyo, Japan
Elyse Swallow1, Caroline Kelley1, James Signorovitch1, Gail Wygant2, Fiona McPhee2
1 Analysis Group, Inc., Boston, MA 2 Bristol-Myers Squibb, Princeton, NJ
|
| |
|
|
|
|
|
